000 | 01758 a2200529 4500 | ||
---|---|---|---|
005 | 20250514022221.0 | ||
264 | 0 | _c20020220 | |
008 | 200202s 0 0 eng d | ||
022 | _a0341-2695 | ||
024 | 7 |
_a10.1007/s002640100273 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKumta, S M | |
245 | 0 | 0 |
_aClinical significance of P-glycoprotein immunohistochemistry and doxorubicin binding assay in patients with osteosarcoma. _h[electronic resource] |
260 |
_bInternational orthopaedics _c2001 |
||
300 |
_a279-82 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xanalysis |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aBiopsy, Needle |
650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
650 | 0 | 4 | _aDrug Resistance |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aOsteonecrosis _xchemically induced |
650 | 0 | 4 |
_aOsteosarcoma _xdrug therapy |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aProbability |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aProtein Binding _xphysiology |
650 | 0 | 4 | _aSensitivity and Specificity |
700 | 1 | _aZhu, Q S | |
700 | 1 | _aLee, K M | |
700 | 1 | _aGriffith, J | |
700 | 1 | _aChow, L T | |
700 | 1 | _aLeung, P C | |
773 | 0 |
_tInternational orthopaedics _gvol. 25 _gno. 5 _gp. 279-82 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002640100273 _zAvailable from publisher's website |
999 |
_c11705371 _d11705371 |